Delivery Order SPE2DB24D3013-SPE2DB24FFHCN
Award Date
8/20/24
Potential Completion Date
8/21/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML. The contract has a ceiling value of $5,833.20 and is a firm fixed price delivery order running through March 7, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,774.92 firm fixed-price delivery order is for the OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML pharmaceutical product. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,687.94 firm fixed-price delivery order is for the pharmaceutical product OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML. The contract has an ultimate completion date of March 20, 2025 and was awarded on March 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,484.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTREXUP 22.5 MG/0.4 ML AUTOINJ 0.4ML, a pharmaceutical product, with a performance period ending on April 29, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,885.73 firm fixed-price delivery order is for the supply of OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML, a specialty medication, to support military treatment programs and facilities. The contract has an ultimate completion date of September 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,841.68, was issued by the Defense Logistics Agency (DLA) to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML, a medication, with a completion date of July 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,330.33, is for the delivery of OTREXUP 15 MG/0.4 ML AUTO-INJ 0.4ML, a medical product, with a completion date of April 1, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML medical products. The firm-fixed-price contract has a ceiling value of $11,517.13 and a completion date of November 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB22D2206|SPE2DB25FGV03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OTREXUP 25 MG/0.4 ML AUTO-INJ 0.4ML, a medical product, with a ceiling value of $1,327.88. This is a firm fixed-price delivery order contract with a performance period through May 2, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,622.71, is for the delivery of OTREXUP 20 MG/0.4 ML AUTO-INJ 0.4ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...